PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19303929-0 2009 Improved bioavailability of darunavir by use of kappa-carrageenan versus microcrystalline cellulose as pelletisation aid. Darunavir 28-37 activation induced cytidine deaminase Canis lupus familiaris 117-120 19303929-1 2009 The aim of this study was to produce pellet formulations containing a high drug load (80%) of the poorly soluble HIV-protease inhibitor darunavir, using wet extrusion/spheronization with kappa-carrageenan or microcrystalline cellulose (MCC) as pelletization aid. Darunavir 136-145 activation induced cytidine deaminase Canis lupus familiaris 258-261